Selinexor: A First-in-Class Nuclear Export Inhibitor for Management of Multiply Relapsed Multiple Myeloma

Peterson, TJ; Orozco, J; Buege, M

Peterson, TJ (reprint author), Mem Sloan Kettering Canc Ctr, Dept Pharm, 1250 First Ave,Schwartz 710, New York, NY 10065 USA.

ANNALS OF PHARMACOTHERAPY, 0; ():

Abstract

Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of selinexor for management of relapsed multiple myeloma (MM). Data Sour......

Full Text Link